Procaps Group SA (PROC)
2.76
+0.14
(+5.34%)
USD |
NASDAQ |
May 31, 16:00
2.71
-0.05
(-1.81%)
After-Hours: 20:00
Procaps Group Enterprise Value: 574.55M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 574.55M |
| May 30, 2024 | 558.76M |
| May 29, 2024 | 574.55M |
| May 28, 2024 | 577.94M |
| May 24, 2024 | 574.55M |
| May 23, 2024 | 557.63M |
| May 22, 2024 | 579.06M |
| May 21, 2024 | 593.73M |
| May 20, 2024 | 591.48M |
| May 17, 2024 | 563.27M |
| May 16, 2024 | 554.24M |
| May 15, 2024 | 555.37M |
| May 14, 2024 | 573.42M |
| May 13, 2024 | 573.43M |
| May 10, 2024 | 570.04M |
| May 09, 2024 | 574.55M |
| May 08, 2024 | 570.04M |
| May 07, 2024 | 572.30M |
| May 06, 2024 | 580.19M |
| May 03, 2024 | 581.32M |
| May 02, 2024 | 598.24M |
| May 01, 2024 | 576.24M |
| April 30, 2024 | 558.76M |
| April 29, 2024 | 557.63M |
| April 26, 2024 | 570.84M |
| Date | Value |
|---|---|
| April 25, 2024 | 570.84M |
| April 24, 2024 | 573.41M |
| April 23, 2024 | 573.42M |
| April 22, 2024 | 568.91M |
| April 19, 2024 | 568.91M |
| April 18, 2024 | 567.78M |
| April 17, 2024 | 565.53M |
| April 16, 2024 | 551.99M |
| April 15, 2024 | 556.50M |
| April 12, 2024 | 566.65M |
| April 11, 2024 | 566.74M |
| April 10, 2024 | 562.14M |
| April 09, 2024 | 556.50M |
| April 08, 2024 | 562.14M |
| April 05, 2024 | 584.71M |
| April 04, 2024 | 584.71M |
| April 03, 2024 | 579.06M |
| April 02, 2024 | 576.81M |
| April 01, 2024 | 591.48M |
| March 28, 2024 | 590.37M |
| March 27, 2024 | 576.81M |
| March 26, 2024 | 601.74M |
| March 25, 2024 | 601.63M |
| March 22, 2024 | 613.48M |
| March 21, 2024 | 613.48M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
509.11M
Minimum
Oct 23 2023
1.294B
Maximum
Oct 20 2021
887.78M
Average
782.40M
Median
May 01 2023
Enterprise Value Benchmarks
| Alvotech | 4.794B |
| Moolec Science SA | 49.97M |
| Perspective Therapeutics Inc | 680.29M |
| Electromed Inc | 114.83M |
| Xtant Medical Holdings Inc | 116.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 8.194M |
| Revenue (Quarterly) | 118.41M |
| Total Expenses (Quarterly) | 105.36M |
| EPS Diluted (Quarterly) | 0.08 |
| Gross Profit Margin (Quarterly) | 57.77% |
| Profit Margin (Quarterly) | 6.92% |
| Earnings Yield | 18.84% |
| Operating Earnings Yield | 11.62% |
| Normalized Earnings Yield | 1.118 |